维普期刊资源整合服务平台（V6.5）

26篇 您的检索式：作者名="DAUD AI"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Spectrum of acticity and mechanism of action of VEGF/PDGF inhibitors显示文摘	Homsi J Daud AI	2007	Cancer Control2007，14，3：	1
2	Valproic acid alters chromatin structure by regulation of chromatin modulation proteins显示文摘	Marchion DC Bicaku E Daud AI	2005	Cancer Res2005，65，9：	1
3	Phase I study of bosutinib, a src/abl tyrosine kinase inhibitor, administered to patients with advanced solid tumors显示文摘	DAUD AI KRISHNAMURTHI SS SALEH MN	2012	Clin Cancer Res2012，18，4：	1
4	Phase I dose-escalation trial of checkpoint kinase 1 inhibitor MK-8776 as monotherapy and in combination with gemcitabine in patients with advanced solid tumors 显示文摘	Daud AI Ashworth MT Strosberg J	2015	Journal of clinical oncology2015，33，9：	1
5	Phenotypic and functional a- nalysis of dendritic cells and clinical outcome in patients with high - risk melanoma treated with adjuvant granulocyte macro- phage colony - stimulating factor 显示文摘	Daud AI MirzaN LenoxB	2008	J Clin Oneol2008，26，19：	1
6	Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma 显示文摘	Daud AI Deconti RC Andrews S	2008	J Clin Oncol2008，26，36：	1
7	Treatment of cutaneous melanoma:current approaches and future prospects显示文摘	Algazi AP Soon CW Daud AI	2010	Cancer Manag Res2010，2，：	1
8	PhaseⅠtrial of interleukin-12plasmid electroporation in patients with metastatic melanoma显示文摘	Daud AI DeConti RC Andrews S	2008	J Clin Oncol2008，26，36：	1
9	Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma显示文摘	Daud AI Deconti RC Andrews S	2008	J Clin Oncol2008，26，36：	1
10	Treatment of cutaneous mel- anoma: current approaches and future prospects 显示文摘	Algazi AP Soon CW Daud AI	2010	Cancer Manag Res2010，2，：	1
11	In vivo synergy between topoisomerase Ⅱ and histone deacetylase inhibitors: predictive correlates显示文摘	Marchion DC Bicaku E Daud AI	2005	Mol Cancer Ther2005，4，12：	1
12	Valproic acid alters chromatin structure by regulation of chromatin modulation proteins 显示文摘	Marchion DC Bicaku E Daud AI	2005	Cancer Res2005，65，9：	1
13	Antitumor activity of the anti-PD-1 monoclonal antibody MK-3475 in melanoma (MEL): Correlation of tumor PD-L1 expression with outcome显示文摘	Daud AI Hamid O Ribas A	2014	Cancer Res2014，74，19：	1
14	Valproic acid alters chromatin structure by regulation of chromatin modulation proteins显示文摘	Marchion DC Bicaku E Daud AI Sullivan DM Munster PN	2005	Cancer Res2005，65，9：	1
15	Spectrum of activity and mechanism of action of VEGF/PDGF inhibitors 显示文摘	Homsi J Daud AI	2007	Cancer Control2007，，3：	1
16	Phase I trial of interleukin12 plasmid electroporation with metastatic melanoma显示文摘	Daud AI Deconti RC Andrews S	2008	J Clin Onco2008，26，36：	1
17	Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma显示文摘	DAUD AI DECONTI RC ANDREWS S	2008	Journal of Clinical Oncology2008，26，36：	1
18	Potentiation of a topoi- somerase I inhibitor, karenitecin, by the histone deacetylase in- hibitor valproic acid in melanoma: translational and phase I / II clinical trial显示文摘	Daud AI Dawson J DeConti RC	2009	Clin Cancer Res2009，15，17：	1
19	Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium 显示文摘	Soonpaa MH Daud AI Koh GY	1994	Science1994，264，：	1
20	Phase I trial of interleu- kin-12 plasmid electroporation in patients with metastatic melano- ma显示文摘	Daud AI DeConti RC Andrews S	2008	J Clin 0ncol2008，26，36：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示